Toxicity of psychotropic drugs in patients with COVID-19: A systematic review.

ABSTRACT:

Objective

Due to the global spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), guidance for the use of psychotropic drugs in this context is necessary. We aimed to review clinical evidence regarding the potential toxicity of psychiatric medications in the context of SARS-CoV-2 infection.

Methods

A systematic search for all types of empirical studies and reviews in a broad set of electronic databases and trial registries was conducted up to the 15th of August 2020.

Results

We identified 3 case series and 4 single-case reports on the occurrence of toxicity induced by various psychotropic drugs (lithium, n = 2; clozapine, n = 5; risperidone n = 2; haloperidol n = 1; duloxetine, n = 1). In addition, we provide a new case report on the possible precipi

SUBMITTER: Sabe M 

PROVIDER: S-EPMC7890235 | biostudies-literature | 2021 May-Jun

REPOSITORIES: biostudies-literature